港股生物科技股集體走強，康諾亞大升超11% | uSMART

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

uSMART

EN

港股生物科技股集體走強，康諾亞大升超11%

格隆匯 03-11 11:11

港股市場生物科技板塊集體上升，其中，東曜藥業-B升超16%，康諾亞-B升超11%，北海康成-B升10%，金斯瑞生物科技升超5%，科笛-B、方達控股、榮昌生物、基石藥業-B升超4%。

康諾亞-B(02162.HK)

科笛-B(02487.HK)

基石藥業-B(02616.HK)

北海康成-B(01228.HK)

東曜藥業-B(01875.HK)

20240429康諾亞-B02162

Relevant Stocks

康諾亞-B(02162.HK)

科笛-B(02487.HK)

基石藥業-B(02616.HK)

北海康成-B(01228.HK)

東曜藥業-B(01875.HK)

Contact Us

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSMART-Facebook-Page

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.